Publications en collaboration avec des chercheurs de Centro Nacional de Investigaciones Oncológicas (21)

2013

  1. Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas

    Blood Cancer Journal, Vol. 3, Núm. 4

  2. Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas

    Haematologica, Vol. 98, Núm. 1, pp. 57-64

2012

  1. MicroRNA signatures in B-cell lymphomas

    Blood Cancer Journal, Vol. 2, Núm. 2

  2. Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array results

    Human Pathology, Vol. 43, Núm. 7, pp. 1103-1112

2011

  1. Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cells

    Modern Pathology, Vol. 24, Núm. 5, pp. 698-707

2010

  1. Aggressive large B-cell lymphoma with plasma cell differentiation: Immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

    Haematologica, Vol. 95, Núm. 8, pp. 1342-1349

  2. Amolecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

    Blood, Vol. 116, Núm. 8

  3. Intrafollicular neoplasia/in situ follicular lymphoma: Review of a series of 13 cases

    Histopathology

  4. Mantle cell lymphoma: Transcriptional regulation by microRNAs

    Leukemia, Vol. 24, Núm. 7, pp. 1335-1342

2009

  1. E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitt's lymphoma

    Cancer Research, Vol. 69, Núm. 9, pp. 4052-4058

2008

  1. Erratum: Frequency of BCL2 and BCL6 translocations in follicular lymphoma: Relation with histological and clinical features (Leukemia and Lymphoma (2008) vol. 49(1) (95-101))

    Leukemia and Lymphoma

2005

  1. FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma

    Leukemia, Vol. 19, Núm. 12, pp. 2247-2253

  2. Splenic marginal zone lymphoma: Proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis

    Blood, Vol. 106, Núm. 5, pp. 1831-1838

2004

  1. Variability in the degree of expression of phosphorylated IκBα chronic lymphocytic leukemia cases with nodal involvement

    Clinical Cancer Research, Vol. 10, Núm. 20, pp. 6796-6806

2003

  1. Anomalías cromosómicas en el hiperparatiroidismo: Utilidad de la hibridación genómica comparada en el estudio de las hiperplasias paratiroid

    Nefrologia, Vol. 23, Núm. SUPPL.2, pp. 2-6

  2. Chromosomal aberrations, the consequence of refractory hyperparathyroidism: Its relationship with biochemical parameters

    Kidney International, Supplement

  3. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: Analyses using tissue microarrays

    Blood, Vol. 101, Núm. 2, pp. 681-689

  4. Large B-cell lymphoma presenting in the spleen: Identification of different clinicopathologic conditions

    American Journal of Surgical Pathology, Vol. 27, Núm. 7, pp. 895-902

  5. Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations

    Blood, Vol. 101, Núm. 10, pp. 4042-4046

  6. Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A

    Cancer Research, Vol. 63, Núm. 8, pp. 1814-1817